Position
Chief Commercial Officer
Company
MindMed
New YorkBiotechnologyHealth CareTherapeuticsDescription
Mind Medicine (MindMed) Inc. announced the appointment of Matt Wiley as its Chief Commercial Officer (CCO). In this role, Mr Wiley will oversee the Company's commercial vision and strategy as it prepares for the potential launch of its first product, MM120 orally disintegrating tablet (ODT) for generalized anxiety disorder (GAD) and major depressive disorder (MDD.
Quick answer
MindMed Appoints Matt Wiley as Chief Commercial Officer (March 17, 2025). MindMed is based in New York, New York, United States.
- Who is the new Chief Commercial Officer at MindMed?
- MindMed named Matt Wiley Chief Commercial Officer, announced March 17, 2025.
- What did MindMed announce on March 17, 2025?
- Mind Medicine (MindMed) Inc. announced the appointment of Matt Wiley as its Chief Commercial Officer (CCO). In this role, Mr Wiley will oversee the Company's commercial vision and strategy as it prepares for the potential launch of its first product, MM120 orally disintegrating tablet (ODT) for generalized anxiety disorder (GAD) and major depressive disorder (MDD.
- What does MindMed do?
- MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology.
- Where is MindMed based?
- MindMed is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Inoviq Ltd (March 16, 2025), Exubrion Therapeutics (March 18, 2025), Zenas BioPharma (March 19, 2025) and Hyku Biosciences (March 19, 2025) also announced leadership changes within 45 days of MindMed.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Inoviq Ltd Appoints Dr. Emma Ball as Chief Commercial Officer (March 16, 2025)
- Exubrion Therapeutics Appoints Jennifer Kirk as Chief Executive Officer (March 18, 2025)
- Zenas BioPharma Appoints Lisa von Moltke, M.D. as Head of Research and Development and Chief Medical Officer (March 19, 2025)
- Hyku Biosciences Names Keith Wilcoxen as Chief Scientific Officer (March 19, 2025)
- Acrivon Therapeutics Appoints Adam Levy, Ph.D., M.B.A. as Chief Financial Officer (March 14, 2025)
- Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia and Gulf Countries (March 20, 2025)
Who to call at MindMed, and when
A new leader at MindMed brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day MindMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MindMed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MindMed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MindMed changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MindMed changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.